363 related articles for article (PubMed ID: 18755319)
1. Calcium, vitamin D supplementation, and physical function in the Women's Health Initiative.
Brunner RL; Cochrane B; Jackson RD; Larson J; Lewis C; Limacher M; Rosal M; Shumaker S; Wallace R;
J Am Diet Assoc; 2008 Sep; 108(9):1472-9. PubMed ID: 18755319
[TBL] [Abstract][Full Text] [Related]
2. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium-vitamin D randomized controlled trial.
LaCroix AZ; Kotchen J; Anderson G; Brzyski R; Cauley JA; Cummings SR; Gass M; Johnson KC; Ko M; Larson J; Manson JE; Stefanick ML; Wactawski-Wende J
J Gerontol A Biol Sci Med Sci; 2009 May; 64(5):559-67. PubMed ID: 19221190
[TBL] [Abstract][Full Text] [Related]
3. Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative.
Cauley JA; Chlebowski RT; Wactawski-Wende J; Robbins JA; Rodabough RJ; Chen Z; Johnson KC; O'Sullivan MJ; Jackson RD; Manson JE
J Womens Health (Larchmt); 2013 Nov; 22(11):915-29. PubMed ID: 24131320
[TBL] [Abstract][Full Text] [Related]
4. The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women's Health Initiative (WHI) calcium plus vitamin D randomized clinical trial.
Brunner RL; Wactawski-Wende J; Caan BJ; Cochrane BB; Chlebowski RT; Gass ML; Jacobs ET; LaCroix AZ; Lane D; Larson J; Margolis KL; Millen AE; Sarto GE; Vitolins MZ; Wallace RB
Nutr Cancer; 2011; 63(6):827-41. PubMed ID: 21774589
[TBL] [Abstract][Full Text] [Related]
5. Calcium plus vitamin D supplementation and joint symptoms in postmenopausal women in the women's health initiative randomized trial.
Chlebowski RT; Pettinger M; Johnson KC; Wallace R; Womack C; Mossavar-Rahmani Y; Stefanick M; Wactawski-Wende J; Carbone L; Lu B; Eaton C; Walitt B; Kooperberg CL
J Acad Nutr Diet; 2013 Oct; 113(10):1302-10. PubMed ID: 23954097
[TBL] [Abstract][Full Text] [Related]
6. Effects of Calcium, Vitamin D, and Hormone Therapy on Cardiovascular Disease Risk Factors in the Women's Health Initiative: A Randomized Controlled Trial.
Schnatz PF; Jiang X; Aragaki AK; Nudy M; O'Sullivan DM; Williams M; LeBlanc ES; Martin LW; Manson JE; Shikany JM; Johnson KC; Stefanick ML; Payne ME; Cauley JA; Howard BV; Robbins J
Obstet Gynecol; 2017 Jan; 129(1):121-129. PubMed ID: 27926633
[TBL] [Abstract][Full Text] [Related]
7. Concordance of Results from Randomized and Observational Analyses within the Same Study: A Re-Analysis of the Women's Health Initiative Limited-Access Dataset.
Bolland MJ; Grey A; Gamble GD; Reid IR
PLoS One; 2015; 10(10):e0139975. PubMed ID: 26440516
[TBL] [Abstract][Full Text] [Related]
8. The Women's Health Initiative Randomized Trials and Clinical Practice: A Review.
Manson JE; Crandall CJ; Rossouw JE; Chlebowski RT; Anderson GL; Stefanick ML; Aragaki AK; Cauley JA; Wells GL; LaCroix AZ; Thomson CA; Neuhouser ML; Van Horn L; Kooperberg C; Howard BV; Tinker LF; Wactawski-Wende J; Shumaker SA; Prentice RL
JAMA; 2024 May; 331(20):1748-1760. PubMed ID: 38691368
[TBL] [Abstract][Full Text] [Related]
9. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study.
Prentice RL; Pettinger MB; Jackson RD; Wactawski-Wende J; Lacroix AZ; Anderson GL; Chlebowski RT; Manson JE; Van Horn L; Vitolins MZ; Datta M; LeBlanc ES; Cauley JA; Rossouw JE
Osteoporos Int; 2013 Feb; 24(2):567-80. PubMed ID: 23208074
[TBL] [Abstract][Full Text] [Related]
10. Predictors of adherence in the Women's Health Initiative Calcium and Vitamin D Trial.
Brunner R; Dunbar-Jacob J; Leboff MS; Granek I; Bowen D; Snetselaar LG; Shumaker SA; Ockene J; Rosal M; Wactawski-Wende J; Cauley J; Cochrane B; Tinker L; Jackson R; Wang CY; Wu L
Behav Med; 2009; 34(4):145-55. PubMed ID: 19064373
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
12. Calcium and vitamin D supplements and health outcomes: a reanalysis of the Women's Health Initiative (WHI) limited-access data set.
Bolland MJ; Grey A; Gamble GD; Reid IR
Am J Clin Nutr; 2011 Oct; 94(4):1144-9. PubMed ID: 21880848
[TBL] [Abstract][Full Text] [Related]
13. Calcium plus vitamin D supplementation and the risk of nonmelanoma and melanoma skin cancer: post hoc analyses of the women's health initiative randomized controlled trial.
Tang JY; Fu T; Leblanc E; Manson JE; Feldman D; Linos E; Vitolins MZ; Zeitouni NC; Larson J; Stefanick ML
J Clin Oncol; 2011 Aug; 29(22):3078-84. PubMed ID: 21709199
[TBL] [Abstract][Full Text] [Related]
14. Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the women's health initiative.
Donneyong MM; Hornung CA; Taylor KC; Baumgartner RN; Myers JA; Eaton CB; Gorodeski EZ; Klein L; Martin LW; Shikany JM; Song Y; Li W; Manson JE
Circ Heart Fail; 2015 Jan; 8(1):49-56. PubMed ID: 25398967
[TBL] [Abstract][Full Text] [Related]
15. Calcium plus vitamin D supplementation and lung cancer incidence among postmenopausal women in the Women's Health Initiative.
Tao MH; Dai Q; Chen S; Freudenheim JL; Rohan T; Wakelee H; Datta M; Wactawski-Wende J
Lung Cancer; 2017 Aug; 110():42-47. PubMed ID: 28676217
[TBL] [Abstract][Full Text] [Related]
16. Calcium/vitamin D supplementation, serum 25-hydroxyvitamin D concentrations, and cholesterol profiles in the Women's Health Initiative calcium/vitamin D randomized trial.
Schnatz PF; Jiang X; Vila-Wright S; Aragaki AK; Nudy M; O'Sullivan DM; Jackson R; LeBlanc E; Robinson JG; Shikany JM; Womack CR; Martin LW; Neuhouser ML; Vitolins MZ; Song Y; Kritchevsky S; Manson JE
Menopause; 2014 Aug; 21(8):823-33. PubMed ID: 24594863
[TBL] [Abstract][Full Text] [Related]
17. Calcium and vitamin D supplementation do not influence menopause-related symptoms: Results of the Women's Health Initiative Trial.
LeBlanc ES; Hedlin H; Qin F; Desai M; Wactawski-Wende J; Perrin N; Manson JE; Johnson KC; Masaki K; Tylavsky FA; Stefanick ML
Maturitas; 2015 Jul; 81(3):377-83. PubMed ID: 26044075
[TBL] [Abstract][Full Text] [Related]
18. Urinary tract stone occurrence in the Women's Health Initiative (WHI) randomized clinical trial of calcium and vitamin D supplements.
Wallace RB; Wactawski-Wende J; O'Sullivan MJ; Larson JC; Cochrane B; Gass M; Masaki K
Am J Clin Nutr; 2011 Jul; 94(1):270-7. PubMed ID: 21525191
[TBL] [Abstract][Full Text] [Related]
19. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women's Health Initiative.
de Boer IH; Tinker LF; Connelly S; Curb JD; Howard BV; Kestenbaum B; Larson JC; Manson JE; Margolis KL; Siscovick DS; Weiss NS;
Diabetes Care; 2008 Apr; 31(4):701-7. PubMed ID: 18235052
[TBL] [Abstract][Full Text] [Related]
20. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis.
Bolland MJ; Grey A; Avenell A; Gamble GD; Reid IR
BMJ; 2011 Apr; 342():d2040. PubMed ID: 21505219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]